A medical device maker partnered with IQVIA MedTech to sustain adoption of a reflux-prevention product hit by COVID-19’s impact on elective surgeries. IQVIA recruited and trained 21 reps pre-pandemic and later expanded to 27. Despite shutdowns, the team achieved 85% of quota in 2021 and 95% in 2022, while building awareness and expanding referrals from internists and gastroenterologists. The initiative also created a talent pool for the client’s future hiring. IQVIA’s representative strategy ensured resilience, compliance, and steady growth despite pandemic-related challenges.

Join for free to read